ALK — Alkaloid AD Skopje Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareConservativeMid CapNeutral

Annual balance sheet for Alkaloid AD Skopje, fiscal year end - December 31st, MKD millions except per share, conversion factor applied.

	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	—	—	—	—	—
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	IFRS	IFRS	IFRS	IFRS	MAS
Status:	Final	Final	Final	Final	Final
Cash
Cash and Equivalents
Cash and Short Term Investments	497	287	468	373	424
Net Total Accounts Receivable
Net Total Receivables	2,749	3,018	3,463	4,007	5,433
Total Inventory
Prepaid Expenses
Total Current Assets	7,366	8,293	9,622	10,537	12,418
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	6,452	6,976	8,059	8,251	9,087
Net Intangible Assets
Long Term Investments
Long Term Notes Receivable
Other Long Term Assets
Total Assets	15,879	17,589	19,954	21,471	24,355
Accounts Payable
Payable / Accrued
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	3,475	4,428	5,385	5,966	7,060
Long Term Debt
Total Long Term Debt
Total Debt
Deferred Income Tax
Minority Interest
Total Other Liabilities
Total Liabilities	4,217	5,082	6,163	6,777	8,935
Common Stock
Retained Earnings (Accumulated Deficit)
Treasury Stock
Total Equity	11,662	12,507	13,790	14,694	15,420
Total Liabilities & Shareholders' Equity	15,879	17,589	19,954	21,471	24,355
Total Common Shares Outstanding